Belviq Case Study
Belviq
Belviq (lorcaserin) is used to treat obesity by targeting the chemicals in the brain that influence appetite. Belviq is a serotonin 2C receptor agonist. The medication has shown to reduce food consumption and encourage satiety by selectively activating serotonin 2C receptors in the brain. Belviq in combination with diet and exercise has shown success in weight loss. It is commonly used to treat obesity that may be linked to diabetes, hypercholesterolemia, or hypertension. L.G. was recently started on Belviq 10 mg tablet 1 tablet 2 times a day for weight loss. She was appropriately placed on the standard dose of Belviq, 10 mg administered orally twice daily. Contrave and Phentermine was used previously with success of weight loss but
Belviq (lorcaserin) is used to treat obesity by targeting the chemicals in the brain that influence appetite. Belviq is a serotonin 2C receptor agonist. The medication has shown to reduce food consumption and encourage satiety by selectively activating serotonin 2C receptors in the brain. Belviq in combination with diet and exercise has shown success in weight loss. It is commonly used to treat obesity that may be linked to diabetes, hypercholesterolemia, or hypertension. L.G. was recently started on Belviq 10 mg tablet 1 tablet 2 times a day for weight loss. She was appropriately placed on the standard dose of Belviq, 10 mg administered orally twice daily. Contrave and Phentermine was used previously with success of weight loss but